The Protective and Therapeutic Compositions in Neurological Disorders
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuropharmacology and Neuropathology".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 2133
Special Issue Editor
Interests: synthesis of and pharmacological exploration of heterocyclic nucleus; CNS depressant; anticonvulsant; anticancer; antioxidant; antitubercular activity; monowave assisted synthesis; structural elucidation of organic molecules; molecular docking; dynamics; pharmacophore mapping; 3D-QSAR studies
Special Issue Information
Dear Colleagues,
The design and development of small molecules for the treatment of various neurological disorders are challenging zones in the field of medicinal chemistry. The current Issue focuses on the various class of heterocyclic scaffolds, structure–activity relationships (SARs), and in silico design of enzyme inhibitors, which are used for the management of neurodegenerative disorders, such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). The Issue also focuses on plant-based inhibitors for the management of PD and AD.
Researchers are highly welcome to contribute original articles and in-depth review articles to this Special Issue that may improve our understanding of treatments for neurological disorders.
Prof. Dr. Bijo Mathew
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monoamine oxidase
- acetylcholinestrase
- Parkinson’s disease
- Alzheimer’s disease
- SAR
- in silico drug design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
